| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | aTYR PHARMA INC - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 01.04. | aTyr Pharma, Inc.: aTyr Pharma to Participate in April Investor Conferences | 17 | GlobeNewswire (USA) | ||
| 14.03. | aTyr Pharma Inc reports results for the quarter ended in December - Earnings Summary | 28 | Reuters | ||
| 14.03. | aTYR PHARMA INC - 10-K, Annual Report | 3 | SEC Filings | ||
| 14.03. | Recap: aTyr Pharma Q4 Earnings | 5 | Benzinga.com | ||
| 14.03. | aTyr Pharma GAAP EPS of -$0.25 misses by $0.01 | 6 | Seeking Alpha | ||
| 14.03. | aTYR PHARMA INC - 8-K, Current Report | 3 | SEC Filings | ||
| 14.03. | aTyr Pharma, Inc.: aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update | 187 | GlobeNewswire (Europe) | Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis anticipated to complete enrollment in the second quarter of 2024. Company launches Individual Patient Expanded Access Program (EAP)... ► Artikel lesen | |
| 13.03. | aTyr Pharma's Earnings Outlook | 1 | Benzinga.com | ||
| 28.02. | aTyr Pharma, Inc.: aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2023 Financial Results | 2 | GlobeNewswire (USA) | ||
| 18.01. | aTyr Pharma, Inc.: aTyr Pharma Announces Howard University President Emeritus Dr. Wayne A. I. Frederick as Advisor | 3 | GlobeNewswire (USA) | ||
| 13.11.23 | aTyr Pharma, Inc.: aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023 | 264 | GlobeNewswire (Europe) | SAN DIEGO, Nov. 13, 2023 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from its... ► Artikel lesen | |
| 13.11.23 | aTyr Pharma files for $300M mixed-shelf offering | 5 | Seeking Alpha | ||
| 10.11.23 | aTyr Pharma GAAP EPS of -$0.20, revenue of $0.3M | 2 | Seeking Alpha | ||
| 09.11.23 | aTyr Pharma Inc reports results for the quarter ended in September - Earnings Summary | 5 | Reuters | ||
| 09.11.23 | aTYR PHARMA INC - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 09.11.23 | aTYR PHARMA INC - 8-K, Current Report | 1 | SEC Filings | ||
| 09.11.23 | aTyr Pharma, Inc.: aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update | 173 | GlobeNewswire (Europe) | Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected to complete enrollment early in the second quarter of 2024. Phase 2 EFZO-CONNECT study of efzofitimod in SSc-ILD initiated patient... ► Artikel lesen |
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| EVOTEC | 5.322 |
| SUPER MICRO COMPUTER | 3.356 |
| BYD | 3.052 |
| BAYER | 2.986 |
| NEL | 2.489 |
| APPLE | 2.353 |
| NVIDIA | 2.183 |
| DEUTSCHE BANK | 2.131 |
| TUI | 2.097 |
| TESLA | 1.823 |
| MERCEDES-BENZ | 1.522 |
| AMAZON | 1.429 |
| PLUG POWER | 1.376 |
| VOLKSWAGEN | 1.369 |
| COMMERZBANK | 1.325 |
| AIXTRON SE | 1.212 |
| NOVO NORDISK | 1.200 |
| RHEINMETALL | 1.184 |
| RWE | 1.175 |
| DEUTSCHE LUFTHANSA | 1.138 |
| RENK GROUP | 1.108 |
| PAYPAL | 1.004 |
| PFIZER | 993 |
| DAIMLER TRUCK | 990 |
| BASF | 983 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
